Role of Hydrophobic Substituents on the Terminal Nitrogen of Histamine in Receptor Binding and Agonist Activity: Development of an Orally Active Histamine Type 3 Receptor Agonist and Evaluation of Its Antistress Activity in Mice
journal contributionposted on 2010-05-13, 00:00 authored by Makoto Ishikawa, Rie Shinei, Fumikazu Yokoyama, Miki Yamauchi, Masayo Oyama, Kunihiro Okuma, Takako Nagayama, Kazuhiko Kato, Nobukazu Kakui, Yasuo Sato
The terminal nitrogen atom of histamine was modified with lipophilic substituents to investigate the structure−activity relationship of histamine type 3 receptor (H3R) agonists. The introduction of an alkylated benzene rings maintained or increased the H3R binding affinity. The most potent compound, 4-(2-(4-tert-butylphenylthio)ethyl)-1H-imidazole, possessed in vivo agonistic activity, decreasing brain Nτ-methylhistamine levels in mice after oral administration. It also exhibited antistress activity in the mouse resident−intruder test.
Read the peer-reviewed publication
RoleAgonist ActivityH 3R agonistsantistress activityrelationshipintroductionEvaluationadministrationhistamine type 3 receptorvivo agonistic activitycompoundalkylated benzene ringsOrallyHydrophobic SubstituentsH 3R binding affinityresidentReceptor Bindinglipophilic substituentsAntistress ActivityHistamine Type 3 Receptor AgonistMiceThe terminal nitrogen atomTerminal Nitrogen